{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "regularMarketChangePercent": -11.319439, "regularMarketPrice": 6.385, "earningsTimestamp": 1683663000, "earningsTimestampStart": 1691492400, "earningsTimestampEnd": 1692010800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.049, "sharesOutstanding": 28046800, "bookValue": 6.806, "fiftyDayAverage": 7.238422, "fiftyDayAverageChange": -0.8534217, "fiftyDayAverageChangePercent": -0.11790162, "twoHundredDayAverage": 11.7126465, "twoHundredDayAverageChange": -5.3276463, "twoHundredDayAverageChangePercent": -0.4548627, "marketCap": 3289628, "priceToBook": 0.93814284, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1610092800000, "priceHint": 2, "marketState": "CLOSED", "exchange": "LSE", "shortName": "RESTORBIO, INC. RESTORBIO ORD S", "longName": "Adicet Bio, Inc.", "messageBoardId": "finmb_310073311", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChange": -0.8149996, "regularMarketTime": 1683907630, "regularMarketDayHigh": 6.385, "regularMarketDayRange": "6.385 - 6.385", "regularMarketDayLow": 6.385, "regularMarketVolume": 100, "regularMarketPreviousClose": 7.2, "bid": 0.0, "ask": 0.0, "fullExchangeName": "LSE", "financialCurrency": "USD", "regularMarketOpen": 6.385, "averageDailyVolume3Month": 480, "averageDailyVolume10Day": 488, "fiftyTwoWeekLowChange": 1.1230001, "fiftyTwoWeekLowChangePercent": 0.21341698, "fiftyTwoWeekRange": "5.262 - 21.195", "fiftyTwoWeekHighChange": -14.809999, "fiftyTwoWeekHighChangePercent": -0.69874966, "fiftyTwoWeekLow": 5.262, "fiftyTwoWeekHigh": 21.195, "symbol": "0HX7.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "200 Berkeley Street", "address2": "19th Floor", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "650 503 9095", "website": "https://www.adicetbio.com", "industry": "", "sector": "", "longBusinessSummary": "Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also develops ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors; and ADI-925, a novel engineered CAd gamma delta T cell product candidate targeting tumor stress ligands. Adicet Bio, Inc. is based in Boston, Massachusetts.", "fullTimeEmployees": 132, "companyOfficers": [{"maxAge": 1, "name": "Mr. Chen  Schor BA, CPA, CPA, M.B.A., MBA", "age": 50, "title": "CEO, Pres & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 899576, "fmt": "899.58k", "longFmt": "899,576"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1843, "fmt": "1.84k", "longFmt": "1,843"}}, {"maxAge": 1, "name": "Dr. Aya  Jakobovits Ph.D.", "age": 67, "title": "Founder & Independent Director", "yearBorn": 1955, "fiscalYear": 2022, "totalPay": {"raw": 40000, "fmt": "40k", "longFmt": "40,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Blake  Aftab Ph.D.", "age": 41, "title": "Sr. VP & Chief Scientific Officer", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": {"raw": 675039, "fmt": "675.04k", "longFmt": "675,039"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 22015, "fmt": "22.02k", "longFmt": "22,015"}}, {"maxAge": 1, "name": "Dr. Francesco  Galimi M.D., Ph.D.", "age": 54, "title": "Chief Medical Officer & Sr. VP", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 680365, "fmt": "680.37k", "longFmt": "680,365"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 266029, "fmt": "266.03k", "longFmt": "266,029"}}, {"maxAge": 1, "name": "Mr. Brian Nicholas Harvey", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Donald  Healey Ph.D.", "age": 60, "title": "Chief Technology Officer", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Amy  Locke", "title": "Head of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nancy L. Boman M.D., Ph.D.", "title": "Sr. VP & Chief Regulatory Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}